TrialSite continues to mobilize fact-check services for the mainstream media portrayal of COVID-19-related situations around the world. This time we travel to Brazil, following a Business Insider piece that declared that Brazil’s use of ivermectin as an early state treatment for COVID-19 didn’t work and America should be informed. What follows is a correction of the questionable reporting of Hilary Brueck writing for Business Insider.
First, it should be noted TrialSite employs a team of technical and scientific talent in Brazil. A highly educated group, the TrialSite team in Brazil includes staff that collaborates with research facilities and medical education centers around the country. While the first ten lines of Ms. Brueck’s article stick somewhat with the facts, (e.g., there was a COVID-19 kit issued by the health department for early care) the Business Insider author goes astray later where she declared, “Brazilians quickly discovered—through heart-wrenching personal experience—the limits of treating COVID-19 with ivermectin.
TrialSite Brazil points out that the link referenced had nothing to do with proof of the failure of iverme...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).